Variable | Details | Total |
N= | 40 | |
Year | 2013 | 2 (5.0%) |
2014 | 5 (12.5%) | |
2015 | 12 (30.0%) | |
2016 | 7 (17.5%) | |
2017 | 2 (5.0%) | |
2018 | 1 (2.5%) | |
2019 | 9 (22.5%) | |
2020 | 2 (5.0%) | |
Resuscitation | no | 12 (30.0%) |
yes | 20 (50.0%) | |
yes 2x | 7 (17.5%) | |
yes 3x | 1 (2.5%) | |
Resuscitation successful | no | 8 (20.0%) |
yes | 12 (30.0%) | |
yes, no | 7 (17.5%) | |
yes 2x, no | 1 (2.5%) | |
/ | 12 (30.0%) | |
Deceased | 19 (47.5%) | |
Status at discharge | ameliorated | 18 (45.0%) |
stationary | 3 (7.5%) | |
deceased | 19 (47.5%) | |
Duration of ICU stay | μ ±SD | 6.70 ±9.57 |
M (min:max) | 4 (0:52) | |
Total hospitalisation | μ ±SD | 10.65 ±9.69 |
M (min:max) | 8.5 (0:52) | |
Sex | F | 17 (42.5%) |
M | 23 (57.5%) | |
Age (years) | μ ±SD | 66.92 ±12.5 |
M (min:max) | 70 (36:88) | |
Residence | rural | 10 (25.0%) |
urban | 30 (75.0%) | |
Dyslipidemia | 21 (70.0%) | |
HTN | 26 (65.0%) | |
DM | 13 (32.5%) | |
Renal Failure | 19 (47.5%) | |
Old MI | 7 (17.5%) | |
Diagnosis of MI | subendocardial | 10 (25.6%) |
transmural | 29 (74.4%) | |
Type of MI | STEMI | 22 (73.3%) |
NSTEMI | 8 (26.7%) | |
Location of MI | anterior | 15 (50.0%) |
anterior-lateral | 1 (3.3%) | |
anterior-septal | 1 (3.3%) | |
inferior | 10 (33.3%) | |
inferior-lateral | 1 (3.3%) | |
septal | 1 (3.3%) | |
transmural | 1 (3.3%) | |
Heart rate | bardycardia | 6 (17.6%) |
normal | 16 (47.1%) | |
tachycardia | 12 (35.3%) | |
Blood pressure | hypotension | 18 (58.1%) |
normal | 6 (19.4%) | |
hypertension | 7 (22.6%) | |
Serum creatinin | decreased | 1 (2.6%) |
normal | 12 (31.6%) | |
increased | 25 (65.8%) | |
RS | 24 (96.0%) | |
Heart rate (bpm) | μ ±SD | 97.25 ±31.5 |
M (min:max) | 95 (35:180) | |
Blocks | 14 (82.4%) | |
Biological changes | 13 (32.5%) | |
Leucocytosis | 32 (94.1%) | |
Prolonged coagulation | 28 (82.4%) | |
Inflammatory sdr. (ESR) | 20 (90.9%) | |
High blood nitrogen | 28 (96.6%) | |
Anemia | 15 (83.3%) | |
Hepatocelulysis | 30 (83.3%) | |
Glycemia | hypo | 2 (5.0%) |
normal | 18 (45.0%) | |
hyper | 20 (50.0%) | |
Acidosis | yes | 31 (77.5%) |
no | 7 (17.5%) | |
alkalosis | 2 (5.0%) | |
LDH | increased | 36 (90.0%) |
normal | 4 (10.0%) | |
K | hypo | 12 (52.2%) |
normal | 2 (8.7%) | |
hyper | 9 (39.1%) | |
Na | hypo | 4 (50.0%) |
normal | 3 (37.5%) | |
hyper | 1 (12.5%) | |
CK-MB | increased | 31 (81.6%) |
normal | 7 (18.4%) | |
LV diameter | dilated | 7 (30.4%) |
normal | 16 (69.6%) | |
LVEF% | μ ±SD | 32.60 ±9.37 |
M (min:max) | 35 (15:50) | |
PHT | 8 (42.1%) | |
Valvulopathies | 22 (56.4%) | |
Tricuspid insufficiency | minimal | 1 (4.8%) |
normal | 6 (28.6%) | |
grade I | 3 (14.3%) | |
grade I/II | 2 (9.5%) | |
grade II | 5 (23.8%) | |
grade III | 3 (14.3%) | |
severe | 1 (4.8%) | |
Aocrtic insufficiency | normal | 14 (70.0%) |
grade I | 2 (10.0%) | |
grade II | 4 (20.0%) | |
Mitral insufficiency | normal | 4 (17.4%) |
mind | 0 | |
grade I | 2 (8.7%) | |
grade I/II | 1 (4.3%) | |
grade II | 8 (34.8%) | |
grade II/III | 1 (4.3%) | |
grade III | 7 (30.4%) | |
D I | 7 (53.8%) | |
D II | 9 (60.0%) | |
CD I | 6 (54.5%) | |
CD II | 3 (42.9%) | |
CD III | 2 (40.0%) | |
C X | 11 (68.8%) | |
OM I | 9 (100%) | |
Cardiogenic shock | 35 (87.5%) | |
Cardiac arrest | no | 11 (27.5%) |
yes | 7 (17.5%) | |
yes: IHCA | 18 (45.0%) | |
yes: OHCA | 4 (10.0%) | |
Arrhythmia | 35 (87.5%) | |
Acidosis | yes | 31 (77.5%) |
no | 7 (17.5%) | |
alkalosis | 2 (5.0%) | |
Pulmonary embolism | 15 (37.5%) | |
Need of ventilatory support at admission | IV | 25 (62.5%) |
NIV | 11 (27.5%) | |
NIV & IV | 4 (10.0%) | |
REHE | 40 (100%) | |
AB | 40 (100%) | |
Gastric antisecretory | 33 (82.5%) | |
Statins | 17 (42.5%) | |
Antiaggreggation | 31 (77.5%) | |
Anticoagulant | 29 (72.5%) | |
Vasoactive | 25 (62.5%) | |
Ionotrop | 27 (67.5%) | |
Sedation | 26 (65.0%) | |
Anti-HBP | 6 (15.0%) | |
Antiarrhythmic | 17 (42.5%) | |
Transfussion | 8 (100%) | |
Cooling | 11 (27.5%) | |
External heating | 1 (2.5%) | |
Diuretics | 19 (100%) | |
Dialysis | 7 (17.5%) | |
Analgetics | 15 (93.8%) | |
Insulin | 4 (10.3%) | |
Standard treatment at discharge | 2 (10.5%) | |
Antiaggregation | 19 (100%) | |
Anticoagulation | 9 (47.4%) | |
Beta-Blocker | 17 (89.5%) | |
ACEi | 10 (55.6%) | |
Statin | 15 (83.3%) | |
Diuretic | 11 (61.1%) | |
Antiarrhythmic | 9 (50.0%) | |
Antisecretory | 6 (33.3%) | |
Antibiotic | 4 (21.1%) | |
Anti-diabetic | 3 (15.8%) | |
Bronchodilator | 3 (15.8%) | |
Hepatoprotector | 1 (5.6%) | |
μ ±SD = Mean (standard deviation); M (min:max) = Median (min:max); | ||